RICHARD HERNANDEZ: Open Payments
NPI 1407615057 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $313 |
| ABBVIE INC. | 6 | $288 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Novo Nordisk Inc | 5 | $102 |
| Exact Sciences Corporation | 2 | $37 |
| Astellas Pharma US Inc | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| TOLMAR, INC. | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, QULIPTA, REXULTI, BREZTRI, Ozempic, Cologuard Collection Kit, Veozah.
Industry payments across SC — which companies pay providers there.
